U.S. flag

An official website of the United States government

NM_001165963.4(SCN1A):c.5591G>C (p.Cys1864Ser) AND Inborn genetic diseases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 22, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002344824.2

Allele description [Variation Report for NM_001165963.4(SCN1A):c.5591G>C (p.Cys1864Ser)]

NM_001165963.4(SCN1A):c.5591G>C (p.Cys1864Ser)

Genes:
SCN1A:sodium voltage-gated channel alpha subunit 1 [Gene - OMIM - HGNC]
LOC102724058:uncharacterized LOC102724058 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
2q24.3
Genomic location:
Preferred name:
NM_001165963.4(SCN1A):c.5591G>C (p.Cys1864Ser)
HGVS:
  • NC_000002.12:g.165991684C>G
  • NG_011906.1:g.86956G>C
  • NM_001165963.4:c.5591G>CMANE SELECT
  • NM_001165964.3:c.5507G>C
  • NM_001202435.3:c.5591G>C
  • NM_001353948.2:c.5591G>C
  • NM_001353949.2:c.5558G>C
  • NM_001353950.2:c.5558G>C
  • NM_001353951.2:c.5558G>C
  • NM_001353952.2:c.5558G>C
  • NM_001353954.2:c.5555G>C
  • NM_001353955.2:c.5555G>C
  • NM_001353957.2:c.5507G>C
  • NM_001353958.2:c.5507G>C
  • NM_001353960.2:c.5504G>C
  • NM_001353961.2:c.3149G>C
  • NM_006920.6:c.5558G>C
  • NP_001159435.1:p.Cys1864Ser
  • NP_001159436.1:p.Cys1836Ser
  • NP_001189364.1:p.Cys1864Ser
  • NP_001340877.1:p.Cys1864Ser
  • NP_001340878.1:p.Cys1853Ser
  • NP_001340879.1:p.Cys1853Ser
  • NP_001340880.1:p.Cys1853Ser
  • NP_001340881.1:p.Cys1853Ser
  • NP_001340883.1:p.Cys1852Ser
  • NP_001340884.1:p.Cys1852Ser
  • NP_001340886.1:p.Cys1836Ser
  • NP_001340887.1:p.Cys1836Ser
  • NP_001340889.1:p.Cys1835Ser
  • NP_001340890.1:p.Cys1050Ser
  • NP_008851.3:p.Cys1853Ser
  • NP_008851.3:p.Cys1853Ser
  • LRG_8t1:c.5558G>C
  • LRG_8:g.86956G>C
  • LRG_8p1:p.Cys1853Ser
  • NC_000002.11:g.166848194C>G
  • NM_001165963.1:c.5591G>C
  • NM_006920.4:c.5558G>C
  • NR_148667.2:n.6008G>C
Protein change:
C1050S
Molecular consequence:
  • NM_001165963.4:c.5591G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165964.3:c.5507G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001202435.3:c.5591G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353948.2:c.5591G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353949.2:c.5558G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353950.2:c.5558G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353951.2:c.5558G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353952.2:c.5558G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353954.2:c.5555G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353955.2:c.5555G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353957.2:c.5507G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353958.2:c.5507G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353960.2:c.5504G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353961.2:c.3149G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006920.6:c.5558G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148667.2:n.6008G>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002649151Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Jun 22, 2020)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV002649151.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.C1864S variant (also known as c.5591G>C), located in coding exon 26 of the SCN1A gene, results from a G to C substitution at nucleotide position 5591. The cysteine at codon 1864 is replaced by serine, an amino acid with dissimilar properties. This variant has been determined to be the result of a de novo mutation or germline mosaicism in one individual with intractable focal epilepsy (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024